May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Characterization of the Genotype and Phenotype of Congenital Stationary Night Blindness in Atlantic Canada
Author Affiliations & Notes
  • B.A. Ford
    Ophthalmology, Dalhousie University, Halifax, NS, Canada
  • J. Beis
    Ophthalmology, IWK Grace Hospital, Halifax, NS, Canada
  • F. Tremblay
    Ophthalmology, IWK Grace Hospital, Halifax, NS, Canada
  • I. DeBecker
    Ophthalmology, IWK Grace Hospital, Halifax, NS, Canada
  • N.T. Bech-Hansen
    Medical Genetics, University of Calgary, Calgary, AB, Canada
  • J. Robitaille
    Medical Genetics, University of Calgary, Calgary, AB, Canada
  • Footnotes
    Commercial Relationships  B.A. Ford, None; J. Beis, None; F. Tremblay, None; I. DeBecker, None; N.T. Bech-Hansen, None; J. Robitaille, None.
  • Footnotes
    Support  IWK Grace Health Centre Foundation
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 1479. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      B.A. Ford, J. Beis, F. Tremblay, I. DeBecker, N.T. Bech-Hansen, J. Robitaille; Characterization of the Genotype and Phenotype of Congenital Stationary Night Blindness in Atlantic Canada . Invest. Ophthalmol. Vis. Sci. 2003;44(13):1479.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To present the spectrum of clinical manifestation of congenital stationary night blindness (CSNB) in families from Atlantic Canada, and to determine the genetic mutation causing the disease in each family. From this information, to determine if there is a correlation between the type and/or location of the mutation and the clinical manifestations of CSNB. Methods: Charts of patients with complete CSNB (cCSNB) or incomplete CSNB (iCSNB) seen at the IWK Health Centre over the past 15 years were reviewed. Diagnosis was based on clinical features and electroretinography (ERG) findings. To determine the mutation responsible for their disease, a sample from each affected individual is obtained for genetic analysis. Results: To date, clinical data is available on 23 individuals with iCSNB from 12 families, and 4 singleton cases of cCSNB. ERG characteristics were consistent within both iCSNB and cCSNB groups. Among iCSNB patients, visual acuity ranged from 6/9 to 6/48, with myopia present in 73% of cases (-1.00 to -16.75). All individuals manifested optic disc pallor to some degree, while other features within the disease spectrum showed greater variability. The causative mutation in six families with iCSNB has been identified thus far. Conclusions: Among affected individuals with iCSNB, some features were consistent whereas others showed considerable variability. This may relate to the mechanism of dysfunction of the causative gene due to different mutations. Correlation of these mutations with the clinical features of affected individuals will give further information on the role of the genetic abnormality in the disease.

Keywords: retina • genetics • clinical (human) or epidemiologic studies: pre 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×